Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health reported full-year 2020 total revenues of $268.7 billion, a 4.6% increase from 2019. GAAP diluted EPS for 2020 was $5.47, while adjusted EPS stood at $7.50. COVID-19 significantly impacted operations, with net income decreasing 44.1% in Q4 compared to 2019, primarily due to a $674 million loss on early debt extinguishment. The company anticipates 2021 GAAP diluted EPS between $6.06 and $6.22. CVS has administered 15 million COVID-19 tests and 3 million vaccines, demonstrating its role in pandemic response.
CVS Health is set to begin administering COVID-19 vaccines at 17 pharmacy locations in South Carolina on February 11. This limited rollout will provide approximately 15,300 doses sourced from a federal pharmacy partnership program. Appointments can be booked starting February 9. The initiative is part of a larger multi-state rollout, including approximately 335 locations across various states, with a goal to eventually administer 20-25 million shots per month. CVS Health continues to expand vaccine accessibility while supporting long-term care facilities.
CVS Health is set to administer COVID-19 vaccines starting February 11, 2021, at 28 pharmacy locations in Virginia. Approximately 26,000 doses will be available through the federal pharmacy partnership program. Appointments can be booked beginning February 9. This vaccine rollout is part of an initial plan covering 11 states, with CVS capable of administering 20-25 million shots monthly. CVS also advances vaccination efforts at over 870 long-term care facilities across Virginia, aiming for complete first doses by mid-February. The company highlights its community presence as key to effective vaccination.
CVS Health is set to begin administering COVID-19 vaccines at 32 pharmacy locations across New York starting February 11, 2021. Appointments can be booked from February 9, with a total supply of approximately 20,600 doses. The initiative is part of a broader 11-state rollout and aims to expand as vaccine supplies increase. CVS focuses on community presence for efficient vaccine distribution. The company is also vaccinating residents at over 1,200 long-term care facilities in New York, with first doses expected to be completed by mid-February.
CVS Health will begin administering COVID-19 vaccines on February 11 at four pharmacy locations in Rhode Island. Appointments can be booked starting February 9 with 3,400 doses available. This initiative is part of a broader rollout across 11 states and aims to leverage CVS's community presence for vaccine distribution. The company plans to expand as more doses become available, with a capacity to administer up to 25 million shots monthly. CVS is also vaccinating residents in over 200 long-term care facilities in Rhode Island.
CVS Health will begin administering COVID-19 vaccines at 70 pharmacy locations in Texas starting February 11, 2021. Approximately 38,000 doses will be available initially, with appointments open for booking on February 9. The rollout is part of an 11-state initiative, with plans to expand as vaccine supply increases. CVS aims to provide 20-25 million shots monthly nationwide, emphasizing community access to vaccines. Additionally, CVS is progressing with vaccination efforts in over 2,000 long-term care facilities in Texas, aiming to complete first doses by mid-February.
CVS Health is set to administer COVID-19 vaccines starting on February 11 at 18 locations in Massachusetts. This initiative is part of a broader rollout across 11 states, with approximately 21,600 doses available. Appointments for vaccinations can be booked from February 9. CVS aims to administer 20-25 million shots monthly as supply increases. The company is also vaccinating staff and residents at over 1,900 long-term care facilities in the state, with first doses expected to be completed by mid-February.
CVS Health will start administering COVID-19 vaccines at 27 pharmacy locations in New Jersey on February 11, 2021. Appointments can be booked from February 9, with approximately 19,900 doses available for the initial rollout. The company is part of a broader initiative to provide vaccines across 11 states, aiming to eventually administer 20-25 million shots per month. Vaccines will be offered to eligible individuals as per state guidelines, with a focus on safety and community presence.
CVS Health (NYSE: CVS) announced it will start administering COVID-19 vaccines at seven Longs Drugs locations in Hawaii from February 11, 2021. Approximately 4,400 doses will be available through the federal pharmacy partnership program. Appointments can be booked starting February 9. CVS plans to eventually offer vaccines across 335 locations in eleven states, aiming to administer 20-25 million vaccines monthly. CVS is also progressing in vaccinating residents at over 45 long-term care facilities in Hawaii.
CVS Health announced that starting February 11, it will administer COVID-19 vaccines at 18 locations in Maryland. This initiative is part of a broader rollout across 11 states, with an initial supply of approximately 11,000 doses. Appointments can be booked from February 9, and only eligible individuals who meet state criteria can receive vaccinations. CVS aims to expand its services as more vaccines become available, with a capacity to administer 20-25 million shots monthly. The company also continues vaccination efforts in over 1,700 long-term care facilities.